Summary Models of T cell recognition suggest that amino acid residues in the CDR3 region of the T cell receptor (TCR) ol or B chain directly contact the major histocompatibility complex-bound peptide, and thus are crucial for providing peptide specificity. T cells derived from B10.PL or PL/J mice of H-2 u haplotype, use only D~/2 and J~2 gene segments in the recognition of the dominant determinant, Acl-9/A u, of myelin basic protein (MBP). New Zealand White (NZW) mice, with identical class II H-2 u genes (I-A and I-E), carry an 8.8-kb deletion in their TCR B chain locus encompassing D~2 and J~2 gene segments. How does this deletion of the crucial DB2-J~2 region in NZW mice influence specific responses to Acl-9/A u as well as to other known A u or E u determinants of MBP? We found that these mice respond very poorly to the dominant Acl-9/A u and to the subdominant 31-50/E u determinant in in vitro proliferation assays as well as in their in vivo capacity to induce experimental autoimmune encephalomyelitis. This loss of response is apparently owing to the absence of high avidity TCRs with essential CDR3 residues contributed by D/32 or J/32 gene segments. These data reveal constraints in the recognition of certain antigenic structures, and further support a TCR-recognition model in which CDtL3 residues of the TCR c~ and ~ chains constitute the antigenic peptide-binding sites on the TCR molecule. Implications for autoimmune manifestations contributed by NZW genes in (NZB x NZW)F1 disease are also discussed.
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T cells recognize peptide-MHC complexes using specific TCR heterodimers (1) . In most peripheral T cells, this recognition is mediated by the TCR-CD3 complex, consisting of invariant CD3 polypeptides (2) in association with polymorphic ol and/3 chains that provide specificity for the recognition of Ag-MHC. As with immunoglobulins, receptor diversity is generated using somatic recombination of variable (V), diversity (D), joining (J), and constant (C) gene segments that encode both chains of the TCR. The homology of Vc~ and V~ sequences to those of VH and VL of Ig suggest that they might display a similar secondary and tertiary structure. X-ray crystallographic studies of Ig have shown that V region domains on each chain form a series of loops that constitute complementarity determining regions (CDR) 1 for antigen binding. Based on Ig structure, models for TCRAg-MHC recognition have been proposed in which the CDR3
1 Abbreviations used in this paper: CDR, complementarity determining region; EAE, experimental autoimmune encephalomyelitis; Gp, guinea pig; m, mouse; MBP, myelin basic protein; NZB, New Zealand black; NZW, New Zealand white. region interacts with the MHC-bound peptide and CDR1 and CDR2 interact with the flanking MHC o~-helices (3) (4) (5) . It has been shown that junctional CDR3 sequences correlate with peptide recognition in T cells with similar specificity (6) (7) (8) (9) (10) . Consistent with this model, mutations in conserved junctional residues result in altered recognition of I-Ek-cytC (11) . R.ecently, direct CDR3-peptide contact has been suggested in a transgenic model for cytochrome C recognition, where substitution of charged residues on the peptide elicited reciprocal charges in CDR3 sequences upon peptide immunization (12) .
New Zealand white (NZW) mice have generated interest because of their role in the autoimmunity of New Zealand black (NZB x NZW)F1 hybrids, which display similar features to those observed in human systemic lupus erythematosus (SLE) (13) . The exact basis of their genetic contribution to the F1 disease is not yet understood. Both H-2-1inked (14-16) as well as TCR genes (17) and other non-MHC background genes have been suggested to be important in disease development. Furthermore, it is clear that although SLE is a B cell-mediated disease, T cells are evidently involved at the initial stages of autoimmunity (18, 19) .
The sequences of I-Ac~, I-Aft, I-Ec~, and I-E~ from NZW mice, originally tissue-typed as the unique haplotype, H-2 z, are actually identical to the respective genes of mice of the H-2 u haplotype, such as B10.PL and PL/J (20, 21) . Initially, most myelin basic protein (MBP)-reactive T cells from B10.PL or PL/J mice respond to the immunodominant NH2-terminal fragment Acl-9, and predominantly use the TCR V~8.2 gene segment (7, 8) . Although, other V~/gene segments (V~13 or V~4) are also used for the recognition of Acl-9-specific T cells in both mouse strains, all T cells that have been analyzed only used the same DE and J~/gene segment cluster, D~/2-J~/2 (see Table 1 ). Moreover, junctional amino acid residues across the third hypervariable region were conserved in spite of N-region variation at the nucleotide level (7, 22) . Importantly, in spite of the different non-MHC genetic background in B10.PL and PL/J mice, TCR. V-gene segment usage was highly similar and restricted in the recognition of Acl-9/A u. Since NZW mice also express identical MHC class II molecules, i.e., I-A u and I-E ~ (20, 21), we were interested in analyzing the TCR-recognition pattern of Acl-9/A u in this mouse strain because of its genomic deletion of an 8.8-kb segment of DNA containing the crucial D~/2 and Jfl2 gene segments (23) . Although, the relative importance of these gene segments in antigen recognition has been demonstrated in congenic strains such as BALB/c and the congenic partner BALB/c.V~/Nzw that bears the D~/2-J~2-deletion (24), responses to specific determinants whose recognition is biased towards the usage of DB2-Jfl2 gene segments have not been analyzed. Would NZW mice, in the absence of this gene cluster, be able to exploit an alternative gene segment in order to respond to Acl-9/A~?
We therefore have asked whether the T cell repertoire is highly constrained in its usage of the DB-JB2 region in the recognition of Acl-9. We have shown that in the absence of genes coding for the appropriate CDR3 region, the NZW mouse simply fails to respond to this dominant determinant on MBP. Likewise, upon peptide immunization, NZW mice are almost nonresponsive to Acl-9/A ~ and 31-50/E u, whereas 
Materials and Methods
Mice. B10.PL and NZW mice were purchased from The Jackson Laboratory (Bar Harbor, ME), and bred under specific pathogenfree conditions in our own colony. Female mice were used at 8-20 wk of age.
TCR Peptides. Peptide Acl-9 was synthesized by C. Miles (Macromolecular Resources, Fort Collins, CO), and MBP Acl-20, MBP31-50, and MBP121-140 were synthesized by S. Horvath (Caltech, Pasadena, CA) using a solid phase technique on a peptide synthesizer (model 430A; Applied Biosystems, Inc., Foster City, CA) and purified on a reversed phase column by high performance liquid chromatography (25) .
Proliferation Assays. For lymph node proliferation assays, mice were immunized subcutaneously with 7 nmol of the mMBP peptides or 100 #g of GpMBP, emulsified (1:1) in CFA (Difco Laboratories, Detroit, MI). The draining popliteal and inguinal lymph nodes were removed 10 d after immunization and a single cell suspension was prepared. Lymph node cells (4 x 105 cells/well) were cultured in 96-well microtiter plates in 200 #1 of serum-free medium (HL-1; Ventrex Laboratories, Portland, ME) supplemented with 2 mM glutamine; peptides were added at concentrations ranging from 0.1 to 7 #M, final concentration. Proliferation was assayed by addition of 1 #Ci [3H]thymidine (International Chemical and Nuclear, Irvine, CA) for the last 18 h of a 5-day culture, and incorporation of label was measured by liquid scintillation counting. The antigen processing and presentation capacity of NZW APCs was determined by measuring antigen-specific proliferation of the Acl-9-specific T cell clone, 2C6 (7). T cells (5 x 104-1 x 105 cells/well) were incubated with irradiated spleen cells (1-5 x 105 cells/well) in the presence of MBP or Acl-9 at different concentrations (1 nM to 14 #M). Proliferation of the T cell clone was measured by [3H]thymidine incorporation for the last 18 h of a 3-day culture as described above.
Induction of Experimental Autoimmune Encephalomyelitis (EAE).
MBP was isolated from the brains of guinea pigs (Pel-Freez Biologicals, Rogers, AK) or mice as described (26) . For induction of EAE, mice were immunized subcutaneously with 100 #g mMBP or its peptides in CFA. 0.1 #g pertussis toxin (List Biological Laboratories Inc., Campbell, CA) was injected in 200 #1 of saline, intravenously, 24 and 72 h later. Mice were observed daily for signs of EAE as previously described (27, 28) and until >60 d after MBP immunization.
Flow Cytometry Analysis.
To determine the expression of V~8.2 + T cells, the following mAbs were used: anti-CD4-PE (GK1.5, Becton Dickinson & Co., Mountain View, CA) and anti-VBS.2 (F23.2) (29). F23.2 antibody was purified from hybridoma supernatants by protein A chromatography. Antibodies were used in PBS containing 1% fetal bovine serum. 106 splenocytes, after red blood cell lysis, were stained with 0.5 #g of antibody in a total volume of 50 #1 at 4~ for 30 rain. Cells were washed twice with PBS and then resuspended in 50 #1 of a 1:50 dilution of goat anti-mouse FITC (Southern Biotechnology Associates, Birmingham, AL). After 20 rain at 4~ cells were washed, fixed with 1% paraformaldehyde in PBS, and analyzed using a cytofluorograph (Becton Dickinson & Co.). 
Results and Discussion
MBP Does Not Induce the Dominant Acl-9-specific T Cells. To determine the consequences for the dominance of response to Acl-9 in the absence of critical D/3-J~/genes, both NZW (Fig. 1 A) and B10.PL (Fig. 1 B) mice were immunized with MBP and the T cell proliferative recall to MBP or Acl-9 was followed in the draining lymph nodes. Comparable responses to MBP were found in both mouse strains. However, the proliferative recall to Acl-9, present in B10.PL mice, was absent in NZW mice immunized with MBP ( Fig. 1 A) . This suggests that these animals either are nonresponsive to Acl-9, or they are able to respond to Acl-9, but in the absence of certain critical CDR3-bearing T cells, Acl-9 behaves as a cryptic determinant and these T cells can not be recalled after MBP immunization (30) .
Peptide Immunization Fails to Stimulate Acl-9/A"-specific T Cells. Proliferative responses to Acl-9 were then tested in mice immunized with the peptide itself emulsified in CFA. Fig. 2 indicates that lymph node cells from NZW mice showed almost no proliferation to Acl-9 (stimulation indices <3), whereas peptide-reactive T cells were readily primed in B10.PL mice. Indeed, the primed T cells could be recalled with MBP in B10.PL mice, indicating dominance of the Acl-9/A uspecific response. Furthermore, immunization as well as in vitro recall with an almost 100-fold higher concentration (700 nmol) of Acl-9 did not result in any significant increase in lymph node proliferation in NZW mice (Fig. 3 B; stimulation indices <3). These observations clearly demonstrate the absence of the T cell proliferative response to Acl-9 in NZW mice and further suggest an essential role for particular amino acid residues in the CDR3 region in the recognition of Acl-9/A u. Other T cells, directed against a cryptic determinant within MBP Acl-20 (region 6-20 of MBP), remain unaffected as peptide-immunization resulted in a comparable proliferative response to that in B10.PL mice (Fig. 2) . Similarly, re- sponses to other downstream determinants of MBP remain unaltered (Kumar, V., K. Stellrecht, M. Meyer, and E. Sercarz, manuscript in preparation).
The Subdominant 31-50/E"-reactive T Cells Fail to Be Primed by Peptide
Immunization. Interestingly, a proliferative response to the subdominant determinant MBP 31-50/E u was also not detected after peptide immunization (Fig. 2) . As with Acl-9/A", challenge and in vitro recall at a 100-fold higher concentration (700 nmol) of MBP 31-50/E u did not show any proliferation (data not shown). It has been shown previously that T cells specific for MBP 35-47 (or 31-50) do not use Vfl8 gene segments (31) . However, Dfl-Jfl gene segments used by 31-50-reactive T cells have not been identified. The absence of a proliferative response to this subdominant determinant of MBP in NZW mice is a strong indication that 31-50/ELspecific T cells also predominantly express Dfl2 or Jfl2 gene segments.
Response to the 121-140/A" Determinant Is Unaffected by the Absence of tile TCR D/82 or Jfl2 Gene Segments.
We then asked whether the response to other known A"-restricted determinants on MBP, for example MBP121-140 (32), was compromised due to deletion of the Dfl2-Jfl2 duster in NZW mice. Mice were immunized subcutaneously with MBP 121-140 and 10 d later, the proliferative response was checked in the draining lymph nodes (Fig. 2) . All mice responded well to this subdominant/cryptic determinant when peptide was used for immunization. Presumably, MBP121-140-reactive T cells use other Dfl and Jfl genes and therefore, response to this determinant was not affected.
Failure to Respond to Aci-9 Is Not Linked to the Peripheral ExFession of the VflS.2 Gene Segment.
To determine whether there might be an overall decrease in VflS.2 + T cells in NZW mice, we next examined their expression in peripheral T cells by flow cytometry. Actually, expression of the Vf18.2 gene segment was significantly increased in NZW mice (CD4+-Vfl8.2 + --9.8%) compared with B10.PL mice (CD4+-VflS.2 + = 5%). The loss of the dominant Acl-9/A ~ response in these mice is therefore not due to lower expression of the Vf18.2 gene segment among mature T cells.
APC from NZW Mice Are Not Defective in Processing MBP or in Presenting Aci-9. One possibility is that NZW mice have an appropriate MHC molecule (A") as well as a T cell repertoire capable of recognizing Acl-9, but a processing defect exists preventing formation of the Acl-9/A" complex. Several factors determine the binding of a given peptide including its availability after antigen processing. A processing defect resulting in genetic unresponsiveness to a hen egg lysozyme determinant by failure to remove a single amino acid hindering peptide binding to MHC has recently been shown (Grewal, I., K. Moudgil, E. E. Sercarz, manuscript submitted for publication). Accordingly, we tested whether NZW splenic APC pulsed with MBP or Acl-9 were able to stimulate an Acl-9-specific T cell clone derived from B10.PL mice. Fig.  4 clearly demonstrates that APCs from NZW mice were able to present Acl-9 to specific T cells in vitro. Also, since NZW APCs were able to stimulate Acl-9-reactive T cells when pulsed with whole MBP, there seemed to be no defect evident in antigen processing. Peptide Immunization Also Fails to Induce a Significant Incidence of EAE. The poor proliferative responses to Acl-9 and 31-50 in NZW mice shown by in vitro assays were further confirmed by monitoring induction of Acl-9 or 31-50-induced EAE as a measure of in vivo response. Table 2 shows that the incidence of disease is extremely low when mice were injected with either of these two determinants with adjuvant and pertussis toxin. However, immunization with whole MBP as well as with other determinants, Acl-20 and MBP 121-140, resulted in a significant incidence of EAE in NZW (33) .
Absence of Critical Residues within CDR3 Constrains T Cell Recognition
Specificity. These data demonstrate constraints in the recognition of certain antigenic structures in spite of the myriad possibilities for TCP, diversity. Presumably, the lack of particular dominant T cells with high avidity TCRs results in nonresponsiveness even to strong antigenic determinants, or "holes in the repertoire." Genetic unresponsiveness to protein antigens has generally been attributed to three different mechanisms: the failure to bind to MHC molecules (34-36); or to holes in the T cell repertoire, even when the peptide binds to MHC (37, 38) ; or to regulatory effects (39) . The absence of an appropriate T cell repertoire capable of recognizing the antigen has been attributed primarily to clonal deletion during thymic tolerance induction (40) or to peripheral clonal exhaustion (41) after a vigorous response. It has been previously demonstrated that the germline deletion of appropriate V/3 gene segments compromises the immune responsiveness to certain antigens (42) . In these studies, chimeric mice with a truncated V~8 ~ repertoire missing the TCR V~88 and Vj813 gene segments and expressing H-2 u MHC genes were unable to devise a response to Acl-9/A u. Here, we have demonstrated that the lack of appropriate genes within the CDR3 region results in the loss of a proliferative response to a dominant and a subdominant self-determinant, probably owing to the absence of high avidity TCRs capable of recognizing the MBP Acl-9/A u or the 31-50/E u complexes, respectively.
As in the comparison of the response to Acl-9/A u in B10.PL and PL/J mice, it has been shown that remarkably similar junctional sequences among TCR/3 chains are employed to respond to a given determinant of sperm whale myoglobin by animals that differ in their non-MHC background genes, including Mls (43) . Thus, the lack of response to Acl-9 in NZW mice suggests that the TCP, structures capable of recognizing this determinant are similar with respect to the usage of DB-J~ gene segments in all three H-2 u haplotypes. Although the presence of extremely low affinity/ frequency T cells of Acl-9/A u or 35-47/Eu-specificity in NZW mice cannot be ruled out, their activity is not detectable with in vitro or in vivo assays. It is possible that low affinity T cells specific for these determinants still exist and are of the Th2 type. These cells usually do not proliferate well and are likely to be poorly encephalitogenic. Thus, holes in the repertoire exist, probably due to the absence of TCP, s employing appropriate D~-J~ gene segments. It seems that the interaction between the TCR structures and their ligands, Acl-9/A u or 31-50/E ~ complexes, is stringent enough to de-mand not only specific V/3 gene segments but also specific residues in the CDR3 region (D/32-JB2), despite the availability of closely related gene segments within the DB1-J~I region. These data favor proposed models of TCK recognition (4, 5, 12) that stress involvement of the region in the neighborhood of the V, (D), and J junctions of the ot and TCR chains in constituting the antigenic peptide-specific sites on the TCR molecule.
We would like to suggest a hypothesis that NZW genes have two functions in promoting autoimmunity in the (NZB x NZW)F1 mouse. First, they provide the H-2 u haplotype which permits immune responsiveness to certain self-determinants; second, they mediate autoimmunity by failing to provide an adequate regulatory repertoire. The deletion of D/32 and JB2 gene segments in NZW mice may not only affect the emergence of effector T cells, for example, specific for Acl-9/A u, but may also affect the appearance of a regulatory T cell repertoire in the F1. In this connection, it is intriguing that (NZB x B10.PL)F1 or (NZB x PL/J)F1 do not develop characteristic anti-DNA antibodies. The lack of this protective regulatory T cell subset (for example, in reference 44) could result in the loss of peripheral tolerance to a self-antigen, leading to autoimmunity (28, 45) .
